Clinical Trial

Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents

Study acronym: PostOb
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates the effects of a postbiotic combination called ABB C3 on reducing body fat and improving metabolic health in children and teenagers. The study consists of a 3-month trial with half participants taking ABB C3 and the other half a placebo, monitoring body composition and blood markers. Afterward, participants can continue with ABB C3 for an additional 3 months. The goal is to determine if ABB C3 is a safe and effective way to help young people improve their health by reducing body fat.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-03-06; most recent amendment 2026-03-19.
Status change: Recruiting → Active, Not Recruiting 2026-03-19
Status change: Not Yet Recruiting → Recruiting 2024-04-19
Trial Details
NCT Number NCT06309121
Lead Sponsor Fundació Sant Joan de Déu
Conditions Obesity, Childhood, Obesity, Adolescent
Enrollment 70 participants
Start Date 2024-04-10
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-23